Fetoscopic laser photocoagulation versus expectant management for stage I twin-to-twin transfusion syndrome: A systematic review and meta-analysis.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
08 2023
Historique:
revised: 24 06 2023
received: 05 05 2023
accepted: 21 07 2023
medline: 15 8 2023
pubmed: 4 8 2023
entrez: 4 8 2023
Statut: ppublish

Résumé

To investigate the outcomes of asymptomatic stage I twin-to-twin transfusion syndrome (stage I TTTS) among patients treated with fetoscopic laser photocoagulation (FLP) versus expectant management. Databases such as PubMed, Web of Science and Scopus were systematically searched from inception up to March 1st, 2022. The primary outcome was at least one fetal survival at birth and secondary outcomes included gestational age at delivery, preterm premature rupture of membranes < 32 weeks, preterm birth < 32 weeks, and single and dual fetal survival. Five studies were included in the meta-analysis. There was no significant difference in terms of at least one survival (odds ratio (OR) = 1.40, 95%CI= (0.26, 7.43), P = 0.70), single survival (OR = 0.87, 95%CI= (0.51, 1.48), P = 0.60) and dual survival (OR = 1.63, 95%CI= (0.74, 3.62), P = 0.23) among FLP and expectant groups. Gestational age at delivery (mean difference = 1.19, 95%CI= (-0.25, 2.63), P = 0.10), the risk of PTB<32 weeks (OR = 0.88, 95%CI= (0.50, 1.54), P = 0.65), and pPROM<32 weeks (OR = 1.80, 95% CI= (0.41, 7.98), P = 0.44) were also comparable between the groups. Routine FLP of the placental anastomoses before 26 weeks of gestation is unlikely to be beneficial among asymptomatic stable stage I TTTS patients without cervical shortening as the procedure does not offer a survival advantage compared with expectant management.

Identifiants

pubmed: 37539833
doi: 10.1002/pd.6413
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1229-1238

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Lewi L, Jani J, Blickstein I, et al. The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study. Am J Obstet Gynecol. 2008;199(5):514.e1-e8. https://doi.org/10.1016/j.ajog.2008.03.050
Senat M.-V, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med. 2004;351(2):136-144. https://doi.org/10.1056/nejmoa032597
Sacco A, Van der Veeken L, Bagshaw E, et al. Maternal complications following open and fetoscopic fetal surgery: a systematic review and meta-analysis. Prenat Diagn. 2019;39(4):251-268. https://doi.org/10.1002/pd.5421
Stirnemann J, Slaghekke F, Khalek N, et al. Intrauterine fetoscopic laser surgery versus expectant management in stage 1 twin-to-twin transfusion syndrome: an international randomized trial. Am J Obstet Gynecol. 2021;224(5):528.e1-e12. https://doi.org/10.1016/j.ajog.2020.11.031
Molina S, Papanna R, Moise KJ, Jr, Johnson A. Management of Stage I twin-to-twin transfusion syndrome: an international survey. Ultrasound Obstet Gynecol. 2010;36(1):42-47. https://doi.org/10.1002/uog.7566
Moher D, Altman DG, Liberati A, Tetzlaff JJE. PRISMA statement. Epidemiology. 2011;22(1):128. https://doi.org/10.1097/ede.0b013e3181fe7825
Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011;2(1):1-12.
Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews: a comparison of the Cochrane collaboration risk of bias tool and the effective public health practice project quality assessment tool: methodological research. J Eval Clin Pract. 2012;18(1):12-18. https://doi.org/10.1111/j.1365-2753.2010.01516.x
Gomez NG, Monson MA, Chon AH, Korst LM, Llanes A, Chmait RH. Outcomes of laser surgery for stage I twin-twin transfusion syndrome. Prenat Diagn. 2022;42(2):172-179. https://doi.org/10.1002/pd.6094
Emery SP, Hasley SK, Catov JM, et al. North American Fetal Therapy Network: intervention vs expectant management for stage I twin-twin transfusion syndrome. Am J Obstet Gynec. 2016;215(3):346.e1-e7. https://doi.org/10.1016/j.ajog.2016.04.024
Wagner MM, Lopriore E, Klumper FJ, et al. Short-and long-term outcome in stage 1 twin-to-twin transfusion syndrome treated with laser surgery compared with conservative management. Am J Obstet Gynecol. 2009;201(3):286.e1-e6. https://doi.org/10.1016/j.ajog.2009.05.034
Yang J, Yuan P.-B, Wei Y, et al. A cohort analysis of patients with stage I twin-to-twin transfusion syndrome from a major referral hospital in Northern China. Matern-Fetal Med. 2019;1(02):73-80. https://doi.org/10.1097/fm9.00000000000000021
Bartin R, Colmant C, Bourgon N, Ville Y, Stirnemann J. Effect of gestational age at laser therapy on perinatal outcome in monochorionic diamniotic pregnancies affected by twin-to-twin transfusion syndrome. BJOG. 2022;129(12):2028-2037. https://doi.org/10.1111/1471-0528.17228
Papanna R, Habli M, Baschat AA, et al. Cerclage for cervical shortening at fetoscopic laser photocoagulation in twin-twin transfusion syndrome. Am J Obstet Gynecol. 2012;206(5):425.e1-e7. https://doi.org/10.1016/j.ajog.2012.02.022
Simpson LL. Twin-twin transfusion syndrome. Am J Obstet Gynecol. 2013;208(1):3-18. https://doi.org/10.1016/j.ajog.2012.10.880
Hessami K, Nassr AA, Sananès N, et al. Perinatal risk factors of neurodevelopmental impairment after fetoscopic laser photocoagulation for twin-twin transfusion syndrome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;58(5):658-668. https://doi.org/10.1002/uog.23706

Auteurs

Ahmed A Nassr (AA)

Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.

Kamran Hessami (K)

Maternal Fetal Care Center, Boston Children's Hospital, Harvard Medical Center, Boston, Massachusetts, USA.

Nikan Zargarzadeh (N)

Maternal Fetal Care Center, Boston Children's Hospital, Harvard Medical Center, Boston, Massachusetts, USA.

Eyal Krispin (E)

Maternal Fetal Care Center, Boston Children's Hospital, Harvard Medical Center, Boston, Massachusetts, USA.

Shayan Mostafaei (S)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.

Mounira A Habli (MA)

Department of Maternal-Fetal Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Ramesha Papanna (R)

Department of Obstetrics, Gynecology and Reproductive Sciences, UT Health Science Center at Houston, Houston, Texas, USA.

Stephen P Emery (SP)

Department of Obstetrics and Gynecology, UPMC Magee Women's Hospital, Pittsburgh, Pennsylvania, USA.

Alireza A Shamshirsaz (AA)

Maternal Fetal Care Center, Boston Children's Hospital, Harvard Medical Center, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH